Molecular Diagnostics at the Point of Care Market Report 2023: New Genotypes Creating New Markets - ResearchAndMarkets.com

09 Jan 2023
www.businesswire.com
Diagnostic Reagents
DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive Guides" report has been added to ResearchAndMarkets.com's offering.
'Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive Guides'
The COVID-19 pandemic is ushering in a new world of point of care diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Point of Care testing move into the Physician's Office or even the Home? How much Covid-19 testing is being done at the Point of Care?
Point of Care testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
Market Dynamics
Market Drivers
New Genotypes Creating New Markets
Aging Population a Boon for All Diagnostics
Developing World Driving ID Dx Growth
Point of Care - Why Centralization is Losing Steam
Self Testing
The Need for Speed
Market Limitations
Lower Costs
Infectious Disease is Declining
Wellness Hurts
Economic Growth improves Living Standards
Key Topics Covered:
1 Market Guides
2 Introduction and Market Definition
3 The Infectious Diseases - Market Analysis by Disease
3.1 HIV - Human Immunodeficiency Virus (AIDS)
3.4 HPV - Human papillomavirus
3.6 CTGC - Chlamydia/Gonorhea
3.8 MRSA - Methicillin-resistant Staphylococcus aureus
3.9 VRE - Vancomycin-resistant Enterococcus
3.10 Blood Screening
3.12 Pandemic Diagnostics
4 Industry Overview
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Distributor and Reagent Supplier
4.1.5 Independent Testing Lab
4.1.6 Public National/regional lab
4.1.7 Hospital lab
4.1.8 Physician Office Labs and Clinics
4.1.9 Audit Body
4.1.10 Certification Body
4.2 The Clinical Laboratory Market Segments
4.2.1 Traditional Market Segmentation
4.2.2 Laboratory Focus and Segmentation
4.3 Industry Structure
4.3.1 Hospital Testing Share
4.3.2 Economies of Scale
4.3.2.1 Hospital vs. Central Lab
4.3.3 Physician Office Lab's
4.3.4 Physician's and POCT
5 Profiles of Key MDx Companies
6 Market Trends
7 Molecular Dx - Infectious Disease Recent Developments
8 The Global Market for Molecular Diagnostics at the Point of Care
9 Global MDx at the Point of Care Markets - By Application
9.5 Other Application
10 Global MDx Markets at the Point of Care - by Technology
10.1 PCR
10.2 NGS/Probe
10.3 Other Technology
11 Global MDx at the Point of Care Markets - by Place
11.1 Hospital Point of Care
11.2 Clinic or Physician Office Lab
11.3 Seniors Facility
11.4 Other Place
12 Global MDx at the Point of Care Markets - by Product
12.1 Instrument
12.2 Cartridge
12.3 Other Product
Companies Mentioned
Applied BioCode
Cepheid (now Danaher)
Chembio
Cue Health
Curetis N.V./Curetis GmbH
Diascopic
Fluxergy
Genetic Signatures
Hologic
Immunexpress
Mindray
Mobidiag
Perkin Elmer
Primerdesign
Quidel
Saw Diagnostics
Seegene
Siemens Healthineers
Sona Nanotech
Vir
For more information about this report visit https://www.researchandmarkets.com/r/z37276
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.